https://www.fda.gov/medical-devices/virtual-town-hall-series-immediately-effect-guidance-coronavirus-covid-19-diagnostic-tests-03252020?utm_campaign=2020-03-20%20Virtual%20Town%20Hall%20for%20the%20Guidance%20on%20Coronavirus%20%28COVID-19%29%20Diagnostic%20Tests&utm_medium=email&utm_source=Eloqua

Virtual Town Hall for the Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests

On Wednesday, March 25, 2020, from 3 pm - 4pm Eastern Time, the U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SAR-CoV-2. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2 and the FDA’s updated policy on COVID-19 Diagnostics issued on March 16, 2020, Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.

View the Town Hall Details

Questions? For general questions, including about this Town Hall, contact Division of Industry and Consumer Education. For specific questions about COVID-19 diagnostic development, contact CDRH-EUA-Templates@fda.hhs.gov.